HDAC1 and HDAC2 (ranked at 3 and 4), among class I HDACs, were reported to regulate the changes in histone acetylation and were associated with HDAC inhibitors that were expected to reverse hypoacetylation levels observed even at the early stages of breast cancer progression [29]. The gene discussed is HDAC1; the disease is breast carcinoma.